1 / 38

Aims

Aims. Describe the activation of the complement cascade via: Classical pathway Alternative pathway Explain how activation of the complement cascade can impact other immunologic processes. Describe clinical implications of complement deficiencies. Readings: Abbas & Lichtman, Chapter 8.

conway
Download Presentation

Aims

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Aims • Describe the activation of the complement cascade via: • Classical pathway • Alternative pathway • Explain how activation of the complement cascade can impact other immunologic processes. • Describe clinical implications of complement deficiencies. • Readings: Abbas & Lichtman, Chapter 8

  2. The Complement Activation Pathways • There are three activation pathways • Classical - C1, C4, C2, C3 • Alternate - properdin pathway • Mannose binding lectin or Lectin – uses MBL to initiate the pathway • All three activation pathways result in the formation of C3 & C5 convertases • They converge at a single terminal pathway

  3. antibody Classical Pathway EC RBC bacteria

  4. Classical Pathway • C1 complex • C1q has the antibody binding sites • C1r and C1s are serine proteases C1-Inhibitor is released upon binding to Ab and this activates C1r & C1s. Roitt’s Essential Immunology 2-2

  5. C1s C1r C1q C1

  6. C4a C1’ C4b

  7. C1’ C4b

  8. C2a C1’ C4b C2b

  9. C1’ C3 a b C4b2b C3 Convertase

  10. C1’ C3a Explosive amplification C4b2b C3b

  11. C1’ C5 a b C4b2b3b C5 Convertase

  12. C1’ C5a C5b C4b2b3b

  13. C1’ C4b2b3b C5b

  14. 8 Na+ and H2O K+ 9 9 9 9 9 9 9 9 6 7 C4b2b3b C5b Terminal Pathway Membrane Attack Complex

  15. Activators of the Alternative Complement Pathway • Anything that hydrolyzes C3 • leukocyte proteases • plasmin • bacteria or bacteral products (LPS, bacterial cell wall components) • aggregated IgA • cobra venom factor • Cellophane • Water “Ticking over”

  16. Alternative Pathway EC RBC C3 bacteria

  17. C3a Alternative Pathway EC RBC C3b bacteria

  18. C3b C3b C3b Alternative Pathway EC RBC bacteria

  19. a b Factor B C3b Alternative Pathway Factor D bacterium

  20. C3b Alternative Pathway Ba Bb bacterium

  21. C3b Properdin C3a C3 Convertase Alternative Pathway C3bBb bacterium

  22. Alternative Pathway Roitt’s Essential Immunology 2-3

  23. Properdin C3a Alternative Pathway C3 binding and cleavage is repeated over and over (explosive amplification) C3bBb C3b bacterium

  24. Properdin C3bnBb C5 Convertase bacterium Alternative Pathway

  25. Properdin Alternative Pathway C5a C5b C3bnBb C5 Convertase bacterium

  26. 8 Na+ and H2O K+ 9 9 9 9 9 9 9 9 6 7 Terminal Pathway C5b C3bnBb Membrane Attack Complex

  27. Terminal Pathway • Formation of the MAC is identical in classical and alternative pathway once C5 convertase is formed. Abbas & Lichtman’s Basic Immunology 8-6

  28. MBL Lectin Pathway EC RBC bacteria Mannose Binding Lectin (MBL) binds terminal mannose residues of proteins and polysaccharides found on bacteria.

  29. MBL Only real difference from the classical pathway is that MBL is substituted for C1 complex during initiation. Terminal Mannose residues

  30. 8 C1’ 9 9 9 9 9 9 9 9 7 6 C4b2b3b C5b C5b Complement Pathway Regulation • C3b by itself has a short half-life (ms) • C3b inactivator (Factor H, DAF, and Factor I) • Break apart stable structures and enzymatically cleave C3b • C1 Inhibitor • Regulates classical pathway by dissociating C1r and C1s from C1q • Can also regulate Lectin pathway by dissociating components of MBL

  31. 8 C1’ 9 9 9 9 9 9 9 9 7 6 C4b2b3b C5b C5b Complement Pathway Regulation • C4 binding protein • Breaks apart C4b2b (classical C3 convertase) • Anaphylatoxin inactivator or serum carboxypeptidase B • Removes terminal arginine residue from C3a,C4a, and C5a. • Vitronectin (S protein) • Serum protein which can bind C567 preventing complete MAC formation

  32. Cells with Complement Receptors Receptor Specificity Functions Cell types CR1 C3b, C4b stimulates phagocytosis RBCs, Mf, PMN, B cells removal of IC by RBCs CR2 C3b, EBV B cell receptor complex B cells Epstein-Barr virus receptor CR3 C3b stimulates phagocytosis Mf, PMNs CR4 C3b stimulates phagocytosis Mf, PMNs C1q C1q binds IC to phagocytes B cells, Mf, platelets endothelial cells

  33. Complement Deficiencies • Deficiency of early cascade members (C1, C4, C2, and C3) • Deficiency in opsonization • Poor phagocytosis resulting in increased infection with encapsulated bacteria. • Poor clearance of IC associated with autoimmune diseases.

  34. Complement Deficiencies Type I Hereditary angioedema • Stress and trauma provoked vasodilatation and edema usually of the skin, extremities, or GI mucosa. • Can be fatal if it involve larynx resulting in asphyxiation. • Deficiency of C1INH • spontaneous generation of bradykinin • spontaneous activation of C1  C4a • production of C2a  C2a kinin

  35. Complement Deficiencies • Deficiency of late cascade members (C5, C6, C7, C8 and C9) • Deficiency in the formation of MAC • C5, C6, C7 or C8 deficiency results in difficulty killing gram negative bacteria (Neisseria meningitidis)

  36. Summary • Complement is a group of serum proteins – activated in an orderly fashion from inactive forms. This leads to “spin-off” peptides that have biological activity. • Three main activation pathways and one terminal pathway that leads to the formation of the MAC. • Complement activation is highly regulated. • Possession of complement component receptors lends cells certain biological activities through interaction with complement. • Deficiencies in complement components exist.

  37. Next Lecture • Antigen capture and presentation • Exogenous and Endogenous antigens. • Readings: Abbas & Lichtman, Chapter 3

  38. Objectives • Describe the similarities and differences between the 3 complement cascade activation pathways. • Classical • Alternative • Lectin (Mannose Binding Lectin) • Describe complement regulation and deficiencies.

More Related